Genentech, Inc. (DNA)

manbearbull (54.60) Submitted: 11/07/07 8:07 PM : Start Price: $73.15 DNA Score: 48.08

Great management, great portfolio. Yes, it's getting harder to move a ship as big as this, and yes, there won't be new drugs approved until at least 2009, but other indications for existing blockbusters like Avastin are coming. The pipeline has some ...

Report this Post Replies: 0 | Reply | Permalink

dustbusterz (39.65) Submitted: 9/06/07 12:33 PM : Start Price: $78.97 DNA Score: 36.79

Qtrly Revenue Growth (yoy):   36.60%
Qtrly Earnings Growth (yoy):   40.70%
Operating Cash Flow (ttm):   2.65B
Return on Assets (ttm):   18.41%
Return on Equity (ttm):   27.33%
with growing revenue. i think this one is set to take off.

Report this Post Replies: 0 | Reply | Permalink

martin7548 (< 20) Submitted: 8/24/06 12:43 AM : Start Price: $81.07 DNA Score: 21.35

They are a good company that has good products in their pipeline and should continue to develop more high end drugs.

Report this Post Replies: 0 | Reply | Permalink

dwelllewd (93.73) Submitted: 12/05/07 9:17 PM : Start Price: $67.62 DNA Score: 57.81

With this pullback, the forward PE is significantly lower than the consensus 5 year forward EPS growth.


More cash than debt.


Strong Proofit margin and return on Equity.


More than 50% of the stock is held by insider...

Report this Post Replies: 1 | Reply | Permalink

bnscBill (31.63) Submitted: 10/20/06 5:24 PM : Start Price: $79.15 DNA Score: 25.25

My friend works for this company. He likes his job alot. With all the good products and my estimation of my friends happiness with his job, I expect this company to continue to do good things in years to come.

Report this Post Replies: 0 | Reply | Permalink

KingPortu (68.23) Submitted: 10/11/07 12:13 PM : Start Price: $75.44 DNA Score: 47.44

Biotech has stunk for what seems like forever, but this company has revenue growth of nearly 40%! Solid balance sheet and a LOT of top line medications. Cancer is more and more prevalent by the day and 'old school' chemo treatments are becoming a thi...

Report this Post Replies: 0 | Reply | Permalink

Shadow14US (35.58) Submitted: 3/13/08 9:29 PM : Start Price: $80.05 DNA Score: 24.90

Slow starter, good growth. Made 12.91% growth in two months.

Report this Post Replies: 0 | Reply | Permalink

skaskaska (49.01) Submitted: 3/13/08 7:06 PM : Start Price: $80.05 DNA Score: 24.90

Not going away

Report this Post Replies: 0 | Reply | Permalink

94HUMMER (< 20) Submitted: 3/13/08 11:16 PM : Start Price: $80.05 DNA Score: 24.90

IMMUNITY, LITERALLY, regardless of int rates, the fundalentals are solid, great history, great market cap,solid pipeline, Long Term or Short

Report this Post Replies: 0 | Reply | Permalink

rollingfine (45.43) Submitted: 3/13/08 4:07 PM : Start Price: $80.05 DNA Score: 24.90

Genentech is a biotech company that provides a number of clinically relevant therapies that are becoming the gold standard in treating cancer. With that in mind, how soon to you think it is going to be before cancer is not longer a threat to the ame...

Report this Post Replies: 0 | Reply | Permalink